|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
1.000
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
1.000
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
1.000
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
1.000
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
1.000
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
1.000
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
1.000
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.999
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.999
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.999
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.999
|
|
|
|
positive regulation of lipid catabolic process
|
GO:0050996 |
6 |
0.998
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.998
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.998
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.998
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.998
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.998
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.998
|
|
|
|
sequestering of triglyceride
|
GO:0030730 |
6 |
0.997
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.996
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.995
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.995
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.995
|
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
6 |
0.995
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.994
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.994
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.994
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.994
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.994
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.994
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.994
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.993
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.993
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.992
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.990
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.990
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.989
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.989
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.988
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.988
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.987
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.985
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.985
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.983
|
|
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.981
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.981
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.981
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.980
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.977
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.977
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.975
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.972
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.970
|
|
|
|
negative regulation of peptide hormone secretion
|
GO:0090278 |
16 |
0.970
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.970
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.970
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.970
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.966
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.964
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.964
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.963
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.961
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.961
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.960
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.960
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.959
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.958
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.958
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.956
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.956
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.954
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.952
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.951
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.949
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.948
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.942
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.942
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.940
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.940
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.939
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.939
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.936
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.932
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.932
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.931
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.931
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.928
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.927
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.924
|
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
5 |
0.919
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.919
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.919
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.918
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.916
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.915
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.909
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.908
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.907
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.906
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.905
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.904
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.898
|
|
|
|
creatinine metabolic process
|
GO:0046449 |
3 |
0.897
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.897
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.897
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.896
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.893
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.890
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.889
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.887
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.886
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.886
|
|
|
|
glutamine family amino acid metabolic process
|
GO:0009064 |
15 |
0.885
|
|
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.885
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.884
|
|
|
|
succinate metabolic process
|
GO:0006105 |
4 |
0.877
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.875
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.875
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.869
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.867
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.867
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.865
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.865
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.865
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.859
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.858
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.856
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.855
|
|
|
|
regulation of response to food
|
GO:0032095 |
10 |
0.855
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.843
|
|
|
|
ovulation from ovarian follicle
|
GO:0001542 |
9 |
0.842
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.842
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.836
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.831
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.831
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.827
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.819
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.816
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.799
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.798
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.798
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.796
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.794
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.793
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.792
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.790
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.785
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.783
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.783
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.782
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.777
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.776
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.770
|
|
|
|
positive regulation of triglyceride catabolic process
|
GO:0010898 |
3 |
0.770
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.770
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.767
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.765
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.764
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.761
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.761
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.760
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.758
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.758
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
18 |
0.757
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.755
|
|
|
|
positive regulation of carbohydrate metabolic process
|
GO:0045913 |
30 |
0.753
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.752
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.749
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.745
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.745
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.743
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.742
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.740
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.738
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.735
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.733
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.733
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.733
|
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.729
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.729
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.728
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.726
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.726
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.720
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.719
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.716
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.711
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.710
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.706
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.706
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
16 |
0.704
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.703
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.697
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.695
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.692
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.692
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.690
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.689
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.673
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.672
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.671
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.666
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.658
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.653
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.650
|
|
|
|
response to ketone
|
GO:1901654 |
15 |
0.649
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.647
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.646
|
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
6 |
0.642
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.637
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.636
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.635
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
21 |
0.635
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.626
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.617
|
|
|
|
cellular response to prostaglandin e stimulus
|
GO:0071380 |
1 |
0.616
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.615
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.610
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.607
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.602
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.601
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.600
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.598
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.596
|
|
|
|
regulation of serotonin uptake
|
GO:0051611 |
2 |
0.595
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.593
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.591
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.589
|
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.586
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.580
|
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.579
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.579
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.576
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.575
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.573
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.573
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.567
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.566
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.565
|
|
|
|
response to food
|
GO:0032094 |
17 |
0.564
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.564
|
|
|
|
cellular response to bile acid
|
GO:1903413 |
1 |
0.561
|
|
|
|
regulation of triglyceride catabolic process
|
GO:0010896 |
5 |
0.560
|
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
1 |
0.559
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.559
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.558
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.557
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.556
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.556
|
|
|
|
development of secondary male sexual characteristics
|
GO:0046544 |
3 |
0.555
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.553
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.552
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.544
|
|
|
|
regulation of carbohydrate catabolic process
|
GO:0043470 |
12 |
0.539
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.538
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.537
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.537
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.537
|
|
|
|
taurine metabolic process
|
GO:0019530 |
4 |
0.535
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.535
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.531
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
0.530
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.526
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.521
|
|
|
|
lipid particle organization
|
GO:0034389 |
7 |
0.519
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.517
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.514
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.510
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.510
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.509
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.509
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.507
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
2 |
0.494
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.494
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.493
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.493
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.492
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.491
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.490
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.482
|
|
|
|
protein nitrosylation
|
GO:0017014 |
4 |
0.481
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.481
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.481
|
|
|
|
response to ammonium ion
|
GO:0060359 |
21 |
0.480
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.480
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.479
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.478
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.476
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.475
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.470
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.468
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.467
|
|
|
|
triglyceride mobilization
|
GO:0006642 |
5 |
0.464
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.464
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.461
|
|
|
|
negative regulation of sequestering of triglyceride
|
GO:0010891 |
2 |
0.459
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.457
|
|
|
|
hormone mediated apoptotic signaling pathway
|
GO:0008628 |
1 |
0.455
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.453
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.453
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.451
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.451
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.450
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.448
|
|
|
|
allantoin metabolic process
|
GO:0000255 |
3 |
0.448
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.447
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.445
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.443
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.441
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.441
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.441
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.440
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.440
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.439
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.438
|
|
|
|
trophectodermal cell proliferation
|
GO:0001834 |
2 |
0.438
|
|
|
|
mammary gland branching involved in pregnancy
|
GO:0060745 |
6 |
0.436
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.433
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.431
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.430
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.430
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.427
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.423
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.421
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.417
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.417
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.416
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.415
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.412
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.412
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.412
|
|
|
|
antral ovarian follicle growth
|
GO:0001547 |
5 |
0.409
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.409
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.408
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.408
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.406
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.404
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.403
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.401
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.399
|
|
|
|
regulation of glucocorticoid secretion
|
GO:2000849 |
5 |
0.398
|
|
|
|
response to lithium ion
|
GO:0010226 |
10 |
0.398
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.391
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.389
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.389
|
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.388
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.388
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.381
|
|
|
|
negative regulation of release of cytochrome c from mitochondria
|
GO:0090201 |
6 |
0.381
|
|
|
|
response to cocaine
|
GO:0042220 |
14 |
0.376
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.375
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.374
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.373
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.371
|
|
|
|
regulation of calcidiol 1 monooxygenase activity
|
GO:0060558 |
1 |
0.370
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.370
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.368
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.363
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.362
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.361
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.361
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.360
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.359
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.357
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.356
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.354
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.354
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.353
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.352
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.352
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.351
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.350
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.349
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.346
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.346
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.346
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.345
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.344
|
|
|
|
regulation of mammary gland involution
|
GO:1903519 |
4 |
0.344
|
|
|
|
primary ovarian follicle growth
|
GO:0001545 |
2 |
0.344
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.343
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.342
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.342
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.341
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.340
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.338
|
|
|
|
prostate gland growth
|
GO:0060736 |
13 |
0.338
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.338
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.337
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.337
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.336
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.335
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.335
|
|
|
|
learning
|
GO:0007612 |
98 |
0.333
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.332
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.331
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.331
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.329
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.329
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.327
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.325
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.323
|
|
|
|
urea metabolic process
|
GO:0019627 |
3 |
0.323
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.318
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.318
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.318
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.318
|
|
|
|
diacylglycerol metabolic process
|
GO:0046339 |
6 |
0.316
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.314
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.314
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.308
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.307
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.304
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.303
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.303
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.301
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.301
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.300
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.299
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.298
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.297
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.297
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.295
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.295
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.290
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.288
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.288
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.286
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.285
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.285
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.284
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.282
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.281
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.279
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.278
|
|
|
|
steroid hormone mediated signaling pathway
|
GO:0043401 |
6 |
0.274
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.272
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.271
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.271
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.269
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.268
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.268
|
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.266
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.265
|
|
|
|
positive regulation of cellular response to insulin stimulus
|
GO:1900078 |
9 |
0.265
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.265
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.263
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.263
|
|
|
|
prostate epithelial cord elongation
|
GO:0060523 |
3 |
0.260
|
|
|
|
negative regulation of muscle adaptation
|
GO:0014745 |
2 |
0.260
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.259
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.258
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.257
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.256
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.256
|
|
|
|
peptidyl cysteine modification
|
GO:0018198 |
8 |
0.255
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.255
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.254
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.253
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.253
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.253
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.250
|
|
|
|
catecholamine uptake involved in synaptic transmission
|
GO:0051934 |
4 |
0.249
|
|
|
|
cell cell signaling involved in metanephros development
|
GO:0072204 |
2 |
0.248
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.247
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.242
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.242
|
|
|
|
response to morphine
|
GO:0043278 |
9 |
0.242
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.242
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.241
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.241
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.239
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.239
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.239
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.238
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.238
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.236
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.236
|
|
|
|
negative regulation of neurotransmitter uptake
|
GO:0051581 |
2 |
0.234
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.234
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.233
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.233
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.232
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.232
|
|
|
|
response to estradiol
|
GO:0032355 |
12 |
0.231
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.229
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.229
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.228
|
|
|
|
arginine metabolic process
|
GO:0006525 |
2 |
0.226
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.225
|
|
